Clinical Trials List
2021-12-01 - 2025-07-31
Phase III
Recruiting6
ICD-10C18.8
Malignant neoplasm of overlapping sites of colon
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.8
Malignant neoplasm of other specified sites of large intestine
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Chueh-Chuan Yen Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mengting Peng Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHOU-CHEN CHEN Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- 詹仁豪 Division of General Surgery
- Peng-Chan Lin Division of Hematology & Oncology
- Po-Wen Lin Division of General Surgery
- 黃盈慈 Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- 陳柏全 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Chih Su Division of Colorectal Surgery
- 黃敬文 Division of Colorectal Surgery
- 蔡祥麟 Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
153 participants
